CONTEXT AND OBJECTIVE: Mycobacterium avium subsp. paratuberculosis (MAP) has attracted the interest of researchers because of similarities between paratuberculosis and Crohn's disease (CD). 
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INTRODUCTION
Crohn's disease (CD) is a chronic inflammatory disease of the human gastrointestinal tract. It has increasing incidence worldwide, and unknown etiology. 1 Paratuberculosis is a form of chronic granulomatous enteritis, caused by Mycobacterium avium subsp. paratuberculosis (MAP), which affects all species of ruminants worldwide. 2 Because of the similarities between paratuberculosis and CD, the possibility of an infectious etiology for this disease has been widely discussed and MAP has attracted the interest of many researchers. 3, 4 MAP has been detected by means of cultures and the polymerase chain reaction (PCR) in patients with CD. 3, [5] [6] [7] [8] Numerous theories about a possible cause for CD have been postulated over the years. 9 Scientific evidence supports the theory of an interaction between a persistent environmental stimulus (such as a microbial antigen) and genetic factors that regulate the immune response and/or function of intestinal mucosa. 10, 11 However, it would be simplistic to conclude that one agent is solely responsible for the etiology of CD: a multifactorial cause is more likely. 4, 12 Several studies investigating these causes have been conducted, and they suggest that, although further research is required, an association between MAP and CD cannot be ruled out. 3, 4, 13 Some researchers believe that most CD cases are not caused by "infection with MAP" although they do not neglect the extremely strong suspicion that MAP plays a role in the pathogenesis of CD.
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OBJECTIVE
The aim of this study was to evaluate the frequency of MAP in fresh and formalin-fixed paraffin-embedded intestinal biopsies, through culture and molecular techniques. The samples were collected from CD patients attending a referral center for treatment of intestinal diseases in the state of Minas Gerais, Brazil.
METHODS
Patients and samples
Fresh tissues
Fresh samples were collected prospectively and randomly, using sterile biopsy forceps, from patients undergoing routine ileocolo- Samples were selected by convenience and their power to detect differences was estimated to be between 50% and 80%, according to Pocock's table 15 (p1 = 0.04; p2 = 0.10; f(α,β) = 4.17).
Tissue processing and MAP cultures
Samples for cultivation were taken to the Bacterial Diseases Laboratory, Universidade Federal de Viçosa (LDBAC-UFV), where they were macerated and decontaminated as described by
Bull et al. 6 and Sechi et al. 8 Briefly, for decontamination, 0.5 ml of 2% NaOH was added to the samples, and they were left to rest for 20 minutes at room temperature. Subsequently, the samples were centrifuged at 3000 x g for 30 minutes; the supernatant was discarded, and the pellet was washed with 10 ml of phosphatebuffered saline (PBS). After washing, the pellet was resuspended To confirm the DNA extraction process, PCR reactions were performed to target a region of the human APC gene, using the primers F (5'-CCC CTC CAA ATG AGT TAG CTG C-3') and R (5'-CTCTGC TTT ATT GTC ATC CAA TTC A-3'). 17 Amplified fragments were viewed by means of electrophoresis, on 1% agarose gel in tris-borate-EDTA (TBE) stained with GelRed nucleic acid gel stain, using an ultraviolet transilluminator. A 100 bp ladder was used as a molecular size marker and ultrapure water was used as a negative control.
Sequencing and genetic analysis
Amplified fragments were extracted and purified from agarose gel using the Wizard SV gel and PCR clean-up system, in accordance with the manufacturer's instructions. Subsequently, both strands were sequenced in triplicate. The sequences were edited using the DNAMAN software, and then compared with the sequence of the MAP K-10 strain, which has been deposited in GenBank, using the Basic Local Alignment Search Tool (BLAST) software, which is available from the National Center for Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.gov).
Histopathological analysis
The samples stored in buffered formalin were processed in accordance with the routine procedures of the Histopathology Laboratory, Veterinary Department, Universidade Federal de Viçosa (DVT/UFV). Paraffin-embedded material was used in preparing slides, which were then stained with Ziehl-Neelsen (ZN) to ascertain whether acid-fast bacilli were present.
Quantitative real time PCR (qRT-PCR)
qRT-PCR was performed on the samples that were found to be positive through PCR. Reactions with absolute quantitation were performed in duplicate on plates with 48 wells using the TaqMan Universal Master Mix II (Applied Biosystems, Foster City, CA, USA). Genomic quantitation of each sample was generated by means of the detection software through the Eco real-time PCR system, and this was compared with the standard curve of the bacterial genome (10 6 to 10 1 copies) using the values of the quantification cycle (Cq) for each reaction. The reaction used the primers MPF (5'-CCG CTA ATT GAG AGA TGC GAT T-3') and MPR (5'-CCA GAC AGG TTG TGC CAC AA-3'), which were based on the IS900 insertion sequence and the specific probe (5'-FAM-ACC TCC GTA ACC GTC ATT GTC CAG ATC A-TAMRA-3'). 18 The initial concentration of the sample for constructing the standard curve was determined by using the follow- 
Statistical analysis
All the statistical analyses were performed using the Statistica 7.0 software (StatSoft Inc, 2007) . The data were subjected to analysis of variance (ANOVA) and means were compared using the F test. In cases of significant differences Tukey's test was used at 5% probability (P < 0.05).
Ethical considerations
This study was approved by the Research Ethics Committee of Universidade Federal de Minas Gerais (UFMG) (ETIC no.
0471.0.203.000-10). All participants provided documented informed consent prior to taking part in this study.
RESULTS
Patients
Fresh samples were collected from 14 male and 11 female patients, whose mean age was 46.5 years, (range 23-74 years; Table 1 ). One hundred and forty-nine formalin-fixed paraffin-embedded samples were collected from 143 patients: 56 males and 87 females whose mean age was 40.5 years (range 2-83 years). Six samples were collected from patients from whom samples were taken at
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two different times. The samples were divided into three groups:
44 from patients with CD, 49 from patients with UC and 56 from patients with nIBD ( Table 2) .
MAP cultures
Fresh samples from CD, UC or nIBD patients did not provide any positive result for viable MAP with any culture medium used in this study, even after 30 weeks. from patients with nIBD. However, these differences between the groups were not statistically significant ( Table 3) . In three fresh samples, fragments of a size similar to what was expected were amplified:
PCR
1/5 (20%) from patients with CD, 1/8 (12.5%) from patients with UC and 1/12 (8.3%) from patients with nIBD. These differences between the groups were not statistically significant ( Table 3) .
Sequencing and genetic analysis
All the amplicons of size 626 bp were sequenced; genetic analysis revealed that these amplicons were 97-99% identical to the sequence of the MAP K-10 strain, which is available in the NCBI database.
Histopathological analysis
Among the formalin-fixed paraffin-embedded samples, acid-fast bacilli were identified (Figure 1 from patients with nIBD. The mean detection rate for acid-fast bacilli in the CD group was 10 times higher than in the UC group (P < 0.01); there were no statistically significant differences between the CD and nIBD groups, or between the UC and nIBD groups ( Table 4) . Among the fresh samples, acid-fast bacilli were detected on 1/25 (4%) of the slides, from one patient with UC.
Acid-fast bacilli were not identified on slides from patients with CD or nIBD. Among the fresh samples, the differences between the groups were not statistically significant ( Table 4 ). Table 4 . Relationship between presence of acid-fast bacilli and clinical groups of patients included in the study
Results followed by the same letters did not differ statistically according to Tukey's test at 5% probability. Paraffin-embedded samples: F = 4.5879, P = 0.0117; fresh samples: F = 1.0686, P = 0.3607. CD = Crohn's disease; UC = ulcerative colitis; nIBD = non-inflammatory bowel disease. 
(12%) 174
Results followed by the same letters did not differ statistically according to Tukey's test at 5% probability. Paraffin-embedded samples: F = 0.1211, P = 0.8860; fresh samples: F = 0.2051, P = 0.8161. CD = Crohn's disease; UC = ulcerative colitis; nIBD = non-inflammatory bowel disease; PCR = polymerase chain reaction. Table 5) .
DISCUSSION
Studies that included children have been more likely to report a positive result for MAP than those with an adult population. Dell'Isola et al. 19 suggested that if the initial MAP infection occurred during childhood, detection of this infection would be more likely in studies among children. However, in the present study, inclusion of children (formalin-fixed paraffin-embedded samples) did not influence our results.
MAP culturing from human intestinal biopsy material is quite difficult, even under optimal conditions. However, several research groups have been able to grow MAP from tissues from patients with CD, using classical culturing methods, with success rates ranging from 0-40%. 13 MAP isolates from humans not only present the usual sample decontamination requirements and have very slow growth, but also occur in spheroplasts (a cell wall-deficient form), which are extremely hard to isolate, recover and maintain in sufficient numbers for studies. 20 Additionally, MAP isolation may also have been negatively affected by the freezing of the samples. It was not possible to work with fresh samples because of the distance between HC/UFMG and LDBAC. Freezing of samples before processing was therefore necessitated and even though a cryoprotectant was used, the ideal would have been for the tissues to have been processed immediately. 6 Although MAP was not isolated in this study, it is important to highlight that MAP has only been recovered from human tissues with CD. This microorganism has never been isolated from patients with UC or nIBD. 13 The PCR results regarding MAP detection have been inconclusive and conflicting. Reports have ranged from 0-100% detection in each group (CD, UC and nIBD) using a variety of different methodologies and target sequences. 3, 4 Contrary to other studies in this field, 5-7 MAP was not detected more frequently among our patients with CD than among those with UC or nIBD. However, other research groups have shown that MAP detection in patients with CD occurs more frequently than in patients with UC or nIBD. 21, 22 In this study, we observed the presence of MAP DNA in intestinal biopsy specimens from eight patients among the 174 samples tested. Previous studies have demonstrated that MAP is difficult to detect reliably and reproducibly by means of PCR on DNA extracted from human tissues. 6 Thus, the use of nonoptimal procedures in processing the samples may result in falsenegative results. Bull et al. 6 indicated several important steps that should be followed in the DNA extraction method, such as processing of fresh tissues (i.e. which have never been frozen); mechanical disturbance to ensure access to MAP DNA; resuspension of the DNA overnight at 4 °C; and nested PCR. In this study, we followed these recommendations wherever possible.
However, as previously mentioned, it was necessary for us to freeze the samples, and this could be one reason for the low MAP detection rate in our results.
Few studies have shown higher frequencies of detection of MAP or acid-fast bacilli in patients with CD. [23] [24] [25] [26] This may be due to the difficulty in detecting MAP in tissue, given that MAP occurs in spheroplast form, and only small quantities of the microorganism are present in the tissues. For as long as these technical limitations remain unresolved, it will continue to be a challenge to demonstrate the presence of MAP in tissues of patients with CD. 13 Considering the small number of PCR-positive samples that were tested for qRT-PCR, we could not make any statistical inferences about the quantities of DNA found in the three groups (CD, UC and nIBD), although we observed that CD patients had higher bacterial loads in both formalin-fixed paraffin-embedded and fresh samples.
Some studies have supported the theory that MAP is present in most individuals. However, it is found in greater quantities in people with CD, thus suggesting that MAP is an organism that is ubiquitous in the environment and that it is an opportunistic pathogen and not a primary cause of CD. 13 In this study, the frequency of MAP detection by means of PCR did not differ between CD, UC and nIBD patients, and although the bacterial load was higher in patients with CD, it is not known whether higher bacterial loads cause higher inflammation scores or whether higher inflammation scores cause higher bacterial loads. One possible explanation may be that the 
CONCLUSION
MAP was present in all the groups of patients analyzed, although the greatest bacterial loads were observed in the CD group. This study supports the view that MAP is a ubiquitous organism that colonizes the mucosal surfaces of the gut, thereby resulting in increased detection in CD patients. This study does not provide evidence for any role played by MAP in Crohn's disease; its role remains controversial and inconclusive. This is the first report on the presence of MAP in biopsy specimens from the human gut in Brazil.
